Abstract
Human parainfluenza virus (hPIV) is a serious human pathogen causing upper and lower respiratory tract disease, yet there are no effective vaccines or therapies to control parainfluenza virus infections. Recently, we found that 4-O-substituted sialic derivatives have potent inhibitory activity against hPIV-1, whereas the anti-influenza inhibitor Zanamivir was less inhibitory. To elucidate the origin of the high potency inhibitory activities of these 4-O-substituted derivatives, we performed correlated fragment molecular orbital (FMO)-interfragment interaction energy (IFIE) analysis for hemagglutinin-neuraminidase (HN) glycoprotein complexes of hPIV with the derivatives and compared them with those for Zanamivir. We found key interactions between the inhibitors and the hPIV HN glycoprotein and identified important factors for the inhibitory activity. These theoretical results will be useful for the development of novel anti-hPIV drugs.
References
Collins, P.L., Chanock, R.M., McIntosh, K.: Parainfluenza viruses. In: Fields, B.N., Knipe, D.M., Howley, P.M. (eds.) Fields Virology, pp. 1205–1241. Lippincott-Raven, Philadelphia (1996)
Murphy, B.R.: Parainfluenza viruses. In: Gorbach, S.L., Bartlett, J.G., Blacklow, N.R. (eds.) Infectious Diseases, pp. 2125–2131. Saunders, Philadelphia (1998)
Henrickson, K.J.: Parainfluenza viruses. Clin. Microbiol. Rev. 16, 242–264 (2003)
Schauer, R., Kelm, S., Reuter, G., Roggentin, P., Shaw, L.: Biochemistry, role of sialic acids. In: Rosenberg, A. (ed.) Biology of the Sialic Acids. Plenum, New York (1995)
Honda, T., Kubo, S., Masuda, T., Arai, M., Kobayashi, Y., Yamashita, M.: Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en. Bioorg. Med. Chem. Lett. 19, 2938–2940 (2009)
Ikeda, K., Sato, M., Torisawa, Y.: Some aspects of sialic acid modification. Curr. Med. Chem. Anti Infect Agent 3, 339–350 (2004)
Wilson, J.C., Thomson, R.J., Dyason, J.C., Florio, P., Quelch, K.J., Abo, S., von Itzstein, M.: The design, synthesis and biological evaluation of neuraminic acid-based probes of Vibrio cholerae sialidase. Tetrahedron-Asymmetry 11, 53–73 (2000)
Smith, P.W., Starkey, I.D., Howes, P.D., Sollis, I.L., Keeling, S.P., Cherry, P.C., von Itzstein, M., Wu, W.Y., Jin, B.: Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents. Eur. J. Med. Chem. 31, 143–150 (1996)
von Itzstein, M., Wu, W.Y., Kok, G.B., Pegg, M.S., Dyason, J.C., Jin, B., Phan, T.V., Smythe, M.L., White, H.F., Oliver, S.W., Colman, P.M., Varghese, J.N., Ryan, D.M., Woods, J.M., Bethell, R.C., Hotham, V.J., Cameron, J.M., Penn, C.R.: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418–423 (1993)
Alymova, I.V., Taylor, G., Takimoto, T., Lin, T.H., Chand, P., Babu, Y.S., Li, C., Xiong, X., Portner, A.: Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob. Agents Chemother. 48, 1495–1503 (2004)
Sato, K., Ikeda, K., Suzuki, T., Aoyama, S., Maki, N., Suzuki, Y., Sato, M.: Synthesis of 4-O-[3-(aryl)prop-2-ynyl]-Neu5Ac2en and its 4-epi-analogs modified at C-4 by Sonogashira coupling reaction. Tetrahedron 63, 7571–7581 (2007)
Lawrence, M.C., Borg, N.A., Streltsov, V.A., Pilling, P.A., Epa, V.C., Varghese, J.N., McKimm-Breschkin, Colman, P.M.: Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335, 1343–1357 (2004)
Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Rob, M.A., Cheeseman, J.R., Montgomery, J.A. Jr., Vreven, T., Kudin, K.N., Burant, J.C., Millam, J.M., Iyengar, S.S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N., Petersson, G.A., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Klene, M., Li, X., Knox, J.E., Hratchian, H.P., Cross, J.B., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R.E., Yazyev, O., Austin, A.J., Cammi, R., Pomelli, C., Ochterski, J.W., Ayala, P.Y., Morokuma, K., Voth, G.A., Salvador, P., Dannenberg, J.J., Zakrzewski, V.G., Dapprich, S., Daniels, A.D., Strain, M.C., Farkas, O., Malick, D.K., Rabuck, A.D., Raghavachari, K., Foresman, J.B., Ortiz, J.V., Cui, Q., Baboul, A.G., Clifford, S., Cioslowski, J., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y., Nanayakkara, A., Challacombe, M., Gill, P.M.W., Johnson, B., Chen, W., Wong, M.W., Gonzalez, C., Pople, J.A., Gaussian 09 (Gaussian, Inc., Wallingford, CT, 2009).
Kitaura, K., Ikeo, E., Asada, T., Nakano, T., Uebayasi, M.: Fragment molecular orbital method: an approximate computational method for large molecules. Chem. Phys. Lett. 313, 701–706 (1999)
Ishikawa, T., Kuwata, K.: Fragment molecular orbital calculation with RI-MP2 method. Chem. Phys. Lett. 474, 195–198 (2009)
Murrell, M.T., Porotto, M., Greengard, O., Poltoratskaia, N., Moscona, A.: A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity. J. Virol. 75, 6310–6320 (2001)
Murrell, M., Porotto, M., Weber, T., Greengard, O., Moscona, A.: Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir). J. Virol. 77, 309–317 (2003)
Suzuki, T., Ikeda, K., Koyama, N., Hosokawa, C., Kogure, T., Takahashi, T., Hidari, K.I.P.J., Miyamoto, D., Tanaka, K., Suzuki, Y.: Inhibition of human parainfluenza virus type 1 sialidase by analogs of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid. Glycoconj. J. 18, 331–337 (2001)
Ikeda, K., Sato, K., Kitani, S., Suzuki, T., Maki, N., Suzuki, Y., Sato, M.: 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogues structurally modified at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1. Bioorg. Med. Chem. 14, 7893–7897 (2006)
Acknowledgments
The study was supported in part by the Grant-in-Aid for Scientific Research <KAKENHI> (C) (grant number 21590128 to H.T.) from the Ministry of Education, Culture, Sports, Science and Technology, (MEXT) Japan. H.T. acknowledges MEXT – Supported Program for the Strategic Research Foundation at Private Universities, 2009-2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Itoh, Y., Sando, A., Ikeda, K. et al. Origin of the inhibitory activity of 4-O-substituted sialic derivatives of human parainfluenza virus. Glycoconj J 29, 231–237 (2012). https://doi.org/10.1007/s10719-012-9384-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-012-9384-3